Key Takeaways
- A quarter of shocks, not structural breaks: LPG shortages, LNG cuts, an ammonia plant shutdown, and delayed fertiliser subsidies all hit at once, compressing both volumes and margins. Management frames these as transient, not permanent.
- The ammonia upcycle is the core bull case now: With the Equinor LNG contract live and global ammonia spreads widening, management sees this as the "right time for ammonia business to turn around and to make money."
- Two new plants arrive next quarter: Gopalpur TAN and Dahej nitric acid are both on track for Q2 FY27 commissioning, with TAN expected to hit 90–95% utilisation by year-end.
- Mining Chemicals is the quiet compounder: Volumes grew 11% for the full year and 27% sequentially in Q4, with the DMSL acquisition adding a new explosives platform.
- What to watch next quarter: Whether the Equinor gas benefit flows visibly into margins, the pace of TAN plant ramp-up, and any normalisation in fertiliser working capital as kharif season pulls inventory.
Operating Environment: The Quarter's Shocks
- LPG shortage hit IPA and labour availability: A sudden LPG shortage constrained propylene supply for the IPA business, while the same shortage plus state elections created a severe shortage of skilled contract manpower, delaying project timelines.
- LNG cuts and ammonia shutdown: LNG supply cuts impacted both the Fertilisers and Chemicals businesses, and a planned ammonia plant shutdown for efficiency improvements dragged ~₹70 crores from the quarter. The plant is now back and performing well.
- Fertiliser subsidies lagged raw material spikes: Sharp increases in phosphoric acid and sulfur costs were not matched by timely or adequate subsidy support, while the government held urea and DAP prices to farmers due to state elections, capping premiums on NPKs.
- China and Russia export bans tightened supply: A Chinese export ban on critical products and a Russian ban on ammonium nitrate exports (now lifted in May 2026) added supply-side pressure, though some Russian supply is expected to resume at different cost levels.
- Project timelines realigned: The skilled labour shortage forced a realignment of project schedules; management says work is now back to full steam.
Sailesh Mehta: "I'm truly happy and grateful to share that our Norwegian suppliers bent over backwards to ensure that the LNG supplies don't get impacted, thanks to the war holdups and all."
Ammonia & Gas: The Equinor Catalyst
- First Equinor LNG cargo landed in May 2026: The maiden cargo under the 15-year contract arrived a few weeks before the call, and more shipment parcels are already lined up for the year. LNG supply is now fully secured via this contract plus an existing minimum take-or-pay arrangement with a local supplier.
- Ammonia is in an upcycle: Management explicitly called the current point in the cycle the "right time for ammonia business to turn around and to make money," acknowledging that the investment case always assumed cyclicality with periods of both high spreads and margin squeezes.
- Equinor benefit flows next quarter: Partial reflection of the lower gas cost from the Equinor contract will be visible in Q1 FY27 results, though management declined to quantify the margin impact.
- Gas cost details withheld: Management declined to share the precise pooled gas price or the exact change the Equinor contract brings, calling it "information still not available for public."
- Ammonia supply for Gopalpur is not a constraint: The company already imports and sells ammonia; the additional quantity needed for the new TAN plant will be sourced through monthly continuous supply contracts with multiple suppliers, with readiness to sign a long-term contract if needed.
Subhash Anand: "When we put in a business case for ammonia, we knew ammonia is a volatile commodity. And there will be a time when ammonia, having a manufacturing facility will give a much higher spread. And there will be time when we'll squeeze on margin in terms of ammonia. So these are the business cycle and business cycle will play both on positive, negative. This point of time, we are in a, I'd say, up cycle and definitely right time for ammonia business to turn around and to make money."
Mining Chemicals & TAN: The Growth Engine
- Strong Q4 recovery: Mining Chemicals volumes rose 12% YoY and 27% sequentially, with full-year growth around 11%. Q4 benefited from mining companies pushing to hit year-end targets.
- TAN prices are firming: International FGAN prices are rising on Russia-Ukraine war disturbances, export bans, and restricted import quantities; domestic prices broadly track international prices. Management declined to give a specific realisation number.
- Gopalpur TAN plant commissioning in Q2 FY27: Both the Gopalpur TAN project and the Dahej nitric acid project remain within their approved capex envelopes and are expected to commission next quarter.
- Ramp-up to 90–95% utilisation by FY27 year-end: Management expects a gradual uptick in capacity utilisation at Gopalpur, reaching at least 90–95% on a TPD basis by the end of this fiscal year, with full utilisation or near-exit levels in FY28.
- DMSL acquisition closed: The explosives unit acquisition strengthens the mining chemical platform, adding downstream capability.
- Russia supply disruption easing: The Russian export ban on ammonium nitrate was lifted earlier in May 2026; some supplies are expected to resume, though at different cost and price levels. One or two Russian plants were also impacted by safety or security reasons.
- India self-reliance angle: Management flagged a "very strong case" that the government may take a different approach to ammonium nitrate imports once domestic capacity, including Deepak's Gopalpur plant, makes India self-reliant.
Tarun Sinha: "As capacities are getting created in India through the fresh investments, one of them being Deepak's in Gopalpur, there is a very strong, I would say, very strong case that Government of India might be thinking that once India becomes completely self-reliant for its ammonium nitrate needs, then maybe a different approach to imports will be looked at."
Crop Nutrition: Premium Strategy Under Pressure
- Quarter hit by multiple headwinds: Lower farm-gate prices, elevated channel inventory, a sharp increase in input costs, and lagging subsidy realignment all compressed the Crop Nutrition business in Q4.
- Premium push validated but constrained: Management tried to push higher premiums to pass on higher costs, but the government's hold on urea and DAP prices during state elections limited the ability to raise NPK premiums. Even so, management cited "very strong validation" that enriched specialty smart fertilisers have crossed farmer price-resistance thresholds on superior yields and quality.
- Specialty share to keep rising: The strategy is to grow the specialty business through new product introductions via R&D and in-sourcing from JV partners, targeting key markets with fast farmer adoption. The specialty share of revenue will keep going up, improving the margin profile.
- Working capital temporarily elevated: Receivables and inventory days rose significantly as the fertiliser business softened and uneven rabi-season rain impacted farmer offtake. Management expects normalisation in the next month or two as kharif season pull begins.
Sailesh Mehta: "the quantum of premiums gives a very strong validation to us that the enriched specialty smart fertilisers that we have brought in have truly crossed the mindset of price boundaries in view of the superior value proposition that they give in terms of better yields and better quality produce."
Industrial Chemicals & IPA: Early Recovery Signs
- IPA hit by weak prices and RGP shortage: The IPA business faced both pricing pressure and constrained availability of refinery-grade propylene. Some help was received from the Petroleum Ministry to source LPG propylene, but refineries are far away so landed costs are higher.
- IPA prices to stay elevated before normalising: Management expects IPA prices to remain elevated for some time before a new normal settles in.
- Nitric acid volume grew healthily: Industrial Chemicals saw healthy nitric acid volume growth during the year, and management noted early signs of recovery in both TAN and Industrial Chemicals with improving spreads.
- Specialty nitric acid still nascent: Specialty nitric acid products are in early-stage commercial trial runs and not yet fully commercialised; too early to contribute meaningfully.
Capital Allocation & Acquisitions
- Chardham Chemicals acquired for ~₹120 crores: The acquisition includes land, licenses, plants, and equipment, with value ascribed to location proximity to market and speed-to-market versus a greenfield build. The unit had no revenue in the last three years, and no large capex is expected for ramp-up or bringing it to Deepak standards.
- Chardham strategy is solutions-led: The plan is to supply products and associated solutions to mines and infrastructure segments that improve the cost of rock and mineral extraction for end consumers. A project team will be formed soon for facility upgradation, and new plants will be added to capitalise on license capacity.
- No revenue or EBITDA guidance for Chardham: Management described the upgrade and plant-addition plan but provided no numbers on expected revenue or EBITDA over the next one to two years.
- Elevated capex in FY27, then normalising: Capex is elevated this year due to the Gopalpur and Dahej projects; from next year onward, it returns to normal maintenance capex in line with the last couple of years.
- Debt guidance withheld: Management declined to give a debt number estimate for FY27, citing the two ongoing capex projects.
- CCD conversion due post ~30 months: Compulsorily convertible debentures issued last year (₹500 crores third-party, ₹300 crores promoter entity) carry a fixed conversion ratio with a fixed number of shares, with conversion due after approximately 30 months from issuance.
- Demerger or subsidiary listing not imminent: Management is committed to walking that path but has yet to take a call on form, shape, and timing; more clarity will come later.
Tarun Sinha: "These products will be supplied in a way and provided to the mines and infrastructure segments in a way that the products and associated solutions are able to improve the cost of rock and mineral extraction of the end consumers. That's the business model, and that's what this investment is aimed to achieve for us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Gopalpur TAN and Dahej nitric acid commissioning | Both projects on track, within approved capex envelope | Q2 FY27 |
| Gopalpur TAN capacity utilisation | Reach at least 90–95% on a TPD basis, gradual uptick | By end of FY27 |
| Gopalpur TAN full utilisation | Full capacity utilisation or near exit-level | FY28 |
| Equinor gas contract benefit | Partial reflection visible in results | Next quarter (Q1 FY27) |
| Working capital normalisation | Elevated fertiliser receivables and inventory to normalise as kharif pull starts | Next 1–2 months |
| Capex normalisation | Return to normal maintenance capex in line with last couple of years | FY28 onward |
| Quality of earnings improvement | Driven by tightening global supply, better gas cost visibility, higher specialty/B2C mix, and new capacity ramp-up | FY27 |
| El Niño impact | Likely to pull down rains somewhat, but impact possibly lesser in company's crop geographies; awaiting granular weather reports | Monsoon season |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue | ₹3,011 cr, full year ₹11,506 cr, up ~12% YoY |
| Consolidated EBITDA | ₹354 cr, full year ₹1,684 cr |
| One-off ammonia shutdown impact | ~₹75 cr impact in Q4 EBITDA |
| PAT | ₹739 cr (full year), decline of ~18% after adjusting prior-year one-time tax credit |
| Mining Chemicals volume growth | +12% YoY and +27% QoQ, full year growth ~11% |
| B2C revenue share (Mining Chemicals) | ~16% of segment revenue, up from 13% last year |
| Specialty & Croptek revenue share (Crop Nutrition) | ~33% of segment revenue, up from 30% last year |
| Net debt | ₹4,824 cr |
| Net debt to EBITDA | ~2.86x |
| Capex during the year | ~₹1,569 cr |
| Gopalpur TAN project completion | ~95% complete, commissioning expected Q2 FY27 |
| Dahej nitric acid project completion | ~86% complete, commissioning expected Q2 FY27 |
| Cumulative project spend (incl. GST & advances) | ~₹3,800 cr, total approved capex ~₹4,650 cr |
| Long-term LNG contract | First shipment received in May 2026 under 15-year contract with Equinor |